Radiation oncology market worth $10.1 billion by 2025

By News Release

The global radiation oncology market size is expected to reach USD 10.1 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to witness a CAGR of 6.5% over the forecast period. Rising prevalence of cancer is the primary factor responsible for substantial growth of the market for radiation oncology.

Technological advancements resulted in increased adoption of radiation oncology as primary cancer treatment. Development of compact advanced radiotherapy options such as CyberKnife, Gamma Knife, and tomotherapy are expected to complement this growth. These advanced methods pose lesser postoperative complications and faster recovery time.

Increasing per capita healthcare expenditure is also an important macroeconomic factor driving market growth. In addition, with the aid of supportive government initiatives and awareness, patients are not hesitant to opt for advanced treatment options. For instance, per capita health expenditure witnessed exponential growth of more than 55.0% from 1995 to 2014, as stated by the World Bank Group.

Browse the full research report with TOC on "Radiation Oncology Market Size, Share & Trends Analysis Report By Product (EBRT, Brachytherapy, SBRT), By Application, By Technology, By Region, Competitive Landscape, And Segment Forecasts, 2018 - 2025" at: https://www.grandviewresearch.com/industry-analysis/radiation-oncology-market

Additional Findings From the Report Suggest:

  • In 2016, external beam radiation therapy (EBRT) including compact advanced radiation therapy, proton therapy, and linear accelerator (LINAC), held a lucrative share by product.
  • Brachytherapy is likely to gain maximum share over the coming years owing to extensive usage for the treatment of prostate and breast cancer.
  • EBRT applications for treatment of prostate, breast, lung, colorectal, and head and neck cancer dominated the market in 2016 by way of application.
  • Image-guided radiation therapy (IGRT) contributed to around 13.0% share in 2016 on the basis of technology. In this method, overall objective is to minimize the exposure to the healthy surrounding tissue.
  • 3D-CRT technology is anticipated to witness a lucrative CAGR over the forecast period.
  • North America held maximum share in global radiation oncology market in 2016. Developed health infrastructure, presence of many multinational players, and high per capita health infrastructure are the key regional growth drivers.
  • Varian Medical Systems; Elekta AB; Accuray Incorporated; Ion Beam Applications SA; C.R. Bard, Inc.; IsoRay, Inc.; Mevion Medical Systems, Nordion (Canada) Inc.; NTP; and Mallinckrodt Public Limited Company are some of the key market players.

Grand View Research has segmented the global radiation oncology market by product, application, technology, and region:

  • Radiation Oncology Product Outlook (Revenue, USD Million, 2014 - 2025)
    • External Beam Radiation Therapy
      • Electron-Emitting High-Energy Linear Accelerators (Linac)
      • Compact Advanced Radiotherapy Systems
        • Cyberknife
        • Gamma Knife
        • Tomotherapy
      • Proton Therapy
        • Cyclotron
        • Synchrotron
    • Brachytherapy
      • Seeds
      • Applicators and Afterloaders
      • Electronic Brachytherapy
    • Systemic Beam Radiation Therapy
    • Others
  • Radiation Oncology Application Outlook (Revenue, USD Million, 2014 - 2025)
    • External Beam Radiation Therapy
      • Prostate Cancer
      • Breast Cancer
      • Lung Cancer
      • Head and Neck Cancer
      • Colorectal Cancer
      • Others
    • Internal Beam Radiation Therapy
      • Prostate Cancer
      • Gynecological Cancer
      • Breast Cancer
      • Cervical Cancer
      • Penile Cancer
      • Others
  • Radiation Oncology Technology Outlook (Volume, Units; Revenue, USD Million, 2014 - 2025)
    • External Beam Radiation Therapy
      • Image-Guided Radiotherapy (IGRT)
      • Intensity Modulated Radiotherapy (IMRT)
      • Stereotactic Technology
      • Proton Beam Therapy
      • 3D Conformal Radiotherapy (3D CRT)
      • Volumetric Modulated Arc Therapy (VMAT)
    • Brachytherapy
      • Low-Dose Rate Brachytherapy
      • High-Dose Rate Brachytherapy
    • Systemic Beam Radiation Therapy
    • Others
  • Radiation Oncology Regional Outlook (Revenue, USD Million, 2014 - 2025)
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
    • Asia Pacific
      • China
      • Japan
    • Latin America
      • Mexico
      • Brazil
    • Middle East & Africa
      • South Africa

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

 

Back To Top

Radiation oncology market worth $10.1 billion by 2025.  Appl Rad Oncol. 

By News Release| September 27, 2018
Categories:  Section

About the Author

News Release

News Release

 



Copyright © Anderson Publishing, Ltd

 2018
    Agility CMS